V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20024812 | 20010533 | 1.54 | 61 | Neo-adjuvant (N) | 2016-09-03 | 2016-09-04 | FEC + DOCETAXEL | 02 | N | 20087654 | FEC + DOCETAXEL |
| 20024813 | 20010534 | null | null | Adjuvant (A) | 2016-03-25 | 2016-03-25 | FEC + DOCETAXEL | 99 | N | 20087664 | FEC + DOCETAXEL |
| 20024814 | 20071125 | 1.63 | 80 | Adjuvant (A) | 2016-01-29 | 2016-02-21 | FEC + DOCETAXEL | 2 | null | 20087665 | FEC + DOCETAXEL |
| 20024815 | 20010535 | 1.56 | 59 | Curative (C) | 2016-05-13 | 2016-05-24 | FEC + DOCETAXEL | 02 | N | 20087666 | FEC + DOCETAXEL |
| 20024816 | 20010535 | 1.64 | 80 | Adjuvant (A) | 2013-12-07 | 2013-12-11 | FEC + DOCETAXEL | 02 | N | 20087666 | FEC + DOCETAXEL |
| 20024817 | 20010536 | 1.57 | 106.5 | Adjuvant (A) | 2017-06-06 | 2017-06-07 | FEC + DOCETAXEL | 02 | N | 20087671 | FEC + DOCETAXEL |
| 20024818 | 20010537 | 1.58 | 75 | Adjuvant (A) | 2014-09-16 | 2014-09-20 | FEC 100 + DOCETAXEL | 2 | null | 20087673 | FEC + DOCETAXEL |
| 20024819 | 20010538 | 1.64 | 84.7 | Adjuvant (A) | 2016-05-09 | 2016-05-18 | FEC 100 + DOCETAXEL | 2 | N | 20087674 | FEC + DOCETAXEL |
| 20024820 | 20010539 | 1.64 | 73.7 | Adjuvant (A) | null | 2015-04-23 | FEC + DOCETAXEL | N | N | 20087680 | FEC + DOCETAXEL |
| 20024821 | 20010539 | 1.53 | null | Adjuvant (A) | null | 2013-12-03 | FEC 100 + DOCETAXEL | null | null | 20087680 | FEC + DOCETAXEL |
| 20024822 | 20010539 | null | null | Adjuvant (A) | 2016-01-01 | 2016-01-06 | FEC + DOCETAXEL | N | N | 20087680 | FEC + DOCETAXEL |
| 20024823 | 20010540 | 1.56 | 94.1 | Adjuvant (A) | 2016-08-11 | 2016-09-03 | FEC + DOCETAXEL | 02 | N | 20087692 | FEC + DOCETAXEL |
| 20024824 | 20010541 | null | null | null | null | 2014-01-17 | FEC + DOCETAXEL | null | null | 20087693 | FEC + DOCETAXEL |
| 20024825 | 20010542 | 1.6 | 60.15 | Adjuvant (A) | 2014-07-04 | 2014-07-04 | FEC + DOCETAXEL | 02 | N | 20087695 | FEC + DOCETAXEL |
| 20024826 | 20010543 | 1.78 | 100 | Adjuvant (A) | 2015-04-29 | 2015-04-29 | FEC + DOCETAXEL | 2 | N | 20087699 | FEC + DOCETAXEL |
| 20024827 | 20010544 | 1.57 | 83.7 | Adjuvant (A) | 2015-09-28 | 2015-10-03 | FEC + DOCETAXEL | N | N | 20087706 | FEC + DOCETAXEL |
| 20024828 | 20010544 | 1.7 | 82.9 | Adjuvant (A) | 2016-11-14 | 2016-11-27 | FEC + DOCETAXEL | 1 | N | 20087706 | FEC + DOCETAXEL |
| 20024829 | 20010545 | 1.53 | 72.6 | Neo-adjuvant (N) | 2013-12-09 | 2013-12-11 | FEC 100 + DOCETAXEL | 2 | N | 20087718 | FEC + DOCETAXEL |
| 20024830 | 20010546 | 1.61 | 64.7 | Neo-adjuvant (N) | 2016-01-15 | 2016-01-16 | FEC + DOCETAXEL | 02 | Y | 20087721 | FEC + DOCETAXEL |
| 20024831 | 20010546 | 1.52 | 78 | Neo-adjuvant (N) | 2017-07-24 | 2017-07-27 | FEC + DOCETAXEL | 02 | null | 20087721 | FEC + DOCETAXEL |
| 20024832 | 20010547 | 1.59 | 68.7 | Adjuvant (A) | 2017-08-23 | 2017-08-30 | FEC 100 + DOCETAXEL | N | N | 20087729 | FEC + DOCETAXEL |
| 20024833 | 20010547 | 1.59 | 81 | Adjuvant (A) | 2018-01-16 | 2018-01-21 | FEC + DOCETAXEL | N | N | 20087729 | FEC + DOCETAXEL |
| 20024834 | 20010547 | 1.6 | 70 | Adjuvant (A) | 2018-02-12 | 2018-02-20 | FEC + DOCETAXEL | 2 | N | 20087729 | FEC + DOCETAXEL |
| 20024835 | 20010548 | 1.58 | 62 | Curative (C) | 2016-12-31 | 2017-01-02 | FEC + DOCETAXEL | 2 | Y | 20087733 | FEC + DOCETAXEL |
| 20024836 | 20010548 | 1.7 | 76.6 | Not known (9) | 2015-08-02 | 2015-08-14 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20087733 | FEC + DOCETAXEL |
| 20024837 | 20010549 | 1.67 | 66 | Adjuvant (A) | 2016-08-10 | 2016-08-17 | FEC + DOCETAXEL | N | N | 20087737 | FEC + DOCETAXEL |
| 20024838 | 20010550 | 1.58 | 70.3 | Curative (C) | 2014-02-27 | 2014-03-06 | FEC + DOCETAXEL | 02 | N | 20087740 | FEC + DOCETAXEL |
| 20024839 | 20010550 | 1.54 | 117 | Adjuvant (A) | 2015-02-04 | 2015-02-18 | FEC + DOCETAXEL | 2 | null | 20087740 | FEC + DOCETAXEL |
| 20024840 | 20010551 | 1.66 | 67 | Adjuvant (A) | 2017-04-20 | 2017-04-30 | FEC + DOCETAXEL | N | N | 20087749 | FEC + DOCETAXEL |
| 20024841 | 20071133 | 1.71 | 97 | Not known (9) | 2016-02-29 | 2016-03-01 | FEC + DOCETAXEL | N | N | 20087750 | FEC + DOCETAXEL |
| 20024842 | 20010552 | 1.68 | 84.8 | Neo-adjuvant (N) | null | 2017-09-06 | FEC + DOCETAXEL | N | null | 20087751 | FEC + DOCETAXEL |
| 20024843 | 20010553 | 1.61 | null | Neo-adjuvant (N) | 2015-02-16 | 2015-02-16 | FEC 100 + DOCETAXEL | N | N | 20087753 | FEC + DOCETAXEL |
| 20024844 | 20010553 | 1.57 | null | Adjuvant (A) | 2014-06-18 | 2014-07-13 | FEC + DOCETAXEL | Y | N | 20087753 | FEC + DOCETAXEL |
| 20024845 | 20010553 | 1.58 | 61.2 | Adjuvant (A) | 2013-11-24 | 2013-12-15 | FEC + DOCETAXEL | N | N | 20087753 | FEC + DOCETAXEL |
| 20024846 | 20010553 | 1.65 | 98.9 | Neo-adjuvant (N) | 2017-12-22 | 2017-12-24 | FEC + DOCETAXEL | 2 | N | 20087753 | FEC + DOCETAXEL |
| 20024847 | 20010553 | 1.7 | 80.7 | Not known (9) | 2015-12-27 | 2015-12-30 | FEC + DOCETAXEL | 2 | N | 20087753 | FEC + DOCETAXEL |
| 20024848 | 20010554 | 1.7 | 82.1 | Not known (9) | 2015-01-24 | 2015-01-26 | FEC + DOCETAXEL | 02 | N | 20087772 | FEC + DOCETAXEL |
| 20024849 | 20010554 | 1.61 | 76.2 | Adjuvant (A) | 2017-03-08 | 2017-03-16 | FEC + DOCETAXEL | 02 | N | 20087772 | FEC + DOCETAXEL |
| 20024850 | 20108536 | 1.67 | 75.9 | Adjuvant (A) | 2017-08-13 | 2017-08-16 | FEC + DOCETAXEL | 02 | null | 20087787 | FEC + DOCETAXEL |
| 20024851 | 20010555 | 1.71 | 58 | Adjuvant (A) | 2017-12-16 | 2017-12-20 | FEC + DOCETAXEL | 2 | N | 20087792 | FEC + DOCETAXEL |
| 20024852 | 20010555 | 1.63 | 68 | Adjuvant (A) | 2013-11-01 | 2013-11-01 | FEC + DOCETAXEL | 2 | Y | 20087792 | FEC + DOCETAXEL |
| 20024853 | 20010556 | 1.66 | 59.9 | Not known (9) | 2016-03-26 | 2016-04-01 | FEC 100 + DOCETAXEL | N | N | 20087797 | FEC + DOCETAXEL |
| 20024854 | 20010556 | 1.65 | 72.2 | Adjuvant (A) | null | 2017-06-19 | FEC + DOCETAXEL | N | N | 20087797 | FEC + DOCETAXEL |
| 20024855 | 20010557 | 1.7 | 95 | Disease modification (D) | 2014-01-02 | 2014-01-04 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20087802 | FEC + DOCETAXEL |
| 20024856 | 20010558 | 1.73 | 77 | Adjuvant (A) | 2015-10-31 | 2015-10-31 | FEC + DOCETAXEL | 02 | N | 20087806 | FEC + DOCETAXEL |
| 20024857 | 20010558 | null | 49.4 | Adjuvant (A) | null | 2013-08-21 | FEC + DOCETAXEL | 99 | N | 20087806 | FEC + DOCETAXEL |
| 20024858 | 20010558 | 1.58 | 100.6 | Adjuvant (A) | 2018-01-01 | 2018-01-05 | FEC + DOCETAXEL | 02 | N | 20087806 | FEC + DOCETAXEL |
| 20024859 | 20010558 | 1.63 | 110 | Adjuvant (A) | 2016-08-01 | 2016-08-02 | FEC 100 + DOCETAXEL | 2 | N | 20087806 | FEC + DOCETAXEL |
| 20024860 | 20010559 | 1.75 | 93.7 | Adjuvant (A) | null | 2014-12-27 | FEC + DOCETAXEL | N | N | 20087816 | FEC + DOCETAXEL |
| 20024861 | 20010559 | 1.52 | 111.1 | Adjuvant (A) | 2015-08-02 | 2015-08-03 | FEC 100 + DOCETAXEL | 02 | N | 20087816 | FEC + DOCETAXEL |